Hematopoietic Clinical Trials

234 recruitingLast updated: May 13, 2026

There are 234 actively recruiting hematopoietic clinical trials across 23 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include Houston, Texas, United States, Rochester, Minnesota, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Hematopoietic Trials at a Glance

234 actively recruiting trials for hematopoietic are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Not Applicable with 77 trials, with the heaviest enrollment activity in Houston, Rochester, and Boston. Lead sponsors running hematopoietic studies include Mayo Clinic, M.D. Anderson Cancer Center, and City of Hope Medical Center.

Browse hematopoietic trials by phase

Treatments under study

About Hematopoietic Clinical Trials

Looking for clinical trials for Hematopoietic? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hematopoietic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hematopoietic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 234 trials

Recruiting
Phase 1

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Leukemia, Lymphocytic, AcuteBlood CancerMyeloid Leukemia, Acute+8 more
National Cancer Institute (NCI)86 enrolled1 locationNCT06904066
Recruiting
Phase 1

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

Hematologic MalignancyRelapsed Pediatric ALLHematopoietic Cell Transplantation
St. Jude Children's Research Hospital70 enrolled1 locationNCT07257419
Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Head and Neck CarcinomaMalignant Solid NeoplasmSarcoma+59 more
Alliance for Clinical Trials in Oncology2,000 enrolled746 locationsNCT05334069
Recruiting
Not Applicable

A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
University of Southern California71 enrolled2 locationsNCT07332312
Recruiting

Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell TransplantationTissue Donors
National Cancer Institute (NCI)2,000 enrolled1 locationNCT03000244
Recruiting

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

Hematopoietic and Lymphoid Cell NeoplasmBronchiolitis Obliterans Syndrome
Fred Hutchinson Cancer Center250 enrolled4 locationsNCT05250037
Recruiting
Not Applicable

Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

Hematopoietic MalignancyLymphatic Diseases
Masonic Cancer Center, University of Minnesota250 enrolled1 locationNCT01451502
Recruiting
Phase 2

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Hematopoietic Stem Cell TransplantationImmunodeficiency
National Cancer Institute (NCI)54 enrolled1 locationNCT05027945
Recruiting
Early Phase 1

Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation
Case Comprehensive Cancer Center20 enrolled1 locationNCT04332341
Recruiting
Early Phase 1

L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center50 enrolled4 locationsNCT07220447
Recruiting
Not Applicable

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
NRG Oncology600 enrolled34 locationsNCT06279013
Recruiting

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Malignant Solid NeoplasmLymphatic System NeoplasmHematopoietic Neoplasms
Wake Forest University Health Sciences3,000 enrolled1 locationNCT06897137
Recruiting
Not Applicable

Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies

Hematopoietic and Lymphatic System Neoplasm
Fred Hutchinson Cancer Center40 enrolled1 locationNCT04829136
Recruiting
Not Applicable

Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Roswell Park Cancer Institute150 enrolled1 locationNCT06565260
Recruiting
Phase 2

Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Acute Graft Versus Host DiseaseGraft-Versus-Host DiseaseALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology42 enrolled1 locationNCT07572669
Recruiting
Not Applicable

Pre-Operative Guided Meditation to Reduce Pre-Operative Anxiety in Patients Undergoing Cancer-Directed Surgery

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center300 enrolled1 locationNCT06949943
Recruiting
Not Applicable

Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplant
University of Michigan Rogel Cancer Center10 enrolled1 locationNCT05945121
Recruiting
Phase 3

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
Children's Oncology Group105 enrolled29 locationsNCT05711667
Recruiting
Phase 4

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationCytomegalovirus Infections+1 more
WeiShi120 enrolled1 locationNCT07569653
Recruiting
Phase 3

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Children's Oncology Group60 enrolled193 locationsNCT06513962